Diabetic Macular Edema Management
Article Sidebar
Main Article Content
Abstract
Article Details
References
Bresnick GH. Diabetic macular edema: a review. Ophthalmology 1986; 93:989-97.
Klein.R, et al. The Wisconsin Epidemiological Study of Diabetic Retinopathy: IV.Diabetic macular edema. Ophthalmology.1984; 91:1464-74.
Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology 1983; 90:1301-17.
Ferrs FL III, Patz A. Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol 1984; 28 (suppl):452-61.
Xia P, Inoguchi T, Kerm T et al. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 1994; 43:1122-9.
Xia P, Aiello LP, Ishii H et al. Characterization of vascular endothelial growth factorûs effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 1996; 98:2018-26.
Mathews MK, Merges C, McLeod DS et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38:2729-41.
The early treatment diabetic retinopathy study research group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report no.1. Arch Ophthalmol 1985; 103:1796-806.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 4. Int Ophthalmol Clin 1987; 27:265-72.
Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology1987; 94:761-74.
Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. ETDRS Report Number 19. Arch Ophthalmol 1995; 113:1144-55.
Patz A, Smith RE.The ETDRS and Diabetes 2000. Ophthalmology 1991; 98(suppl.5): 739-40.
Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect of fluroescein angiographic and other retinal characteristics at baseline: ETDRS report on 19. Arch Opthhalmol 1995; 113:1144-55.
Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report no 12. Ophthalmology 1991; 98(suppl;5)823-33.
Roldan M, Serrano JM. Macular edema and vitreous detachment. Ann Ophthalmol 1989; 21:141-58.
Nasrallah Fp, Jalkh AE, vanCoppenhole F, et al. The role of the vitreous in diabetic macular edma. Ophthlmology 1988; 95: 1335-9.
Yamaguchi Y, Otani T, Kishi S. Resolution of diabetic cystoid macular edema associated with spontaneous vitreofoveal separation. Am J Ophthalmol 2003:135:116-8.
Watanabe M,Oshima Y,Emi K. Optical crosssectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 2000; 129: 264-7.
Lewis H, Abrams GW, Blumenkranz MS, Compo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992; 1992:753-9.
Tachi N, Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996 Aug; 122(2):258-60.
Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol.2005 Mar; 139(3):447-54.
Kumar A, Sinha S, Azad R,Sharma YR, Vohra R. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edemaGraefes Arch Clin Exp Ophthalmol. 2006 Nov 9.
Yanyali A, Nohutcu AF, Horozoglu F, Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol. 2005 May; 139(5):795-801.
Wilson CA, Berkowitz BA, Sato Y ando N, Handa JT, de Juan E Jr . Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110:1155-9.
Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 2005; 80:249-58.
McCuen BW 2nd, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91: 785-8.
Jonas J, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132:425-7.
Martidis A, Duker J, Greenberg P, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109:920-7.
Ozkiris A, Evereklioglu C, Erkilic K, et al. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 2004; 14:543-9.
Jonas JB, Degenring RF, Kamppeter BA, et al. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 2004; 138:158-60.
Jonas JB, Kreissig I, Degenring RF, et al. Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema. Br J Ophthalmol 2005; 89:122.
Sutter FK, Simpson JM, Gillies MC. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three month efficacy and safety. Ophthalmology 2004 Nov; 111(11):2044-9.
Mason JO 3rd, Albert MA Jr, Vail R.Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina. 2006 Mar; 26(3):356-7.
Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL, Sorenson J, Slakter JS, Freund KB, Cooney M, Fine HF. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006 Mar; 26(3):279-84.
A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti-Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema. Ophthalmology 2005 Oct; 112(10): 1747-57.